30 companies, 12 Judges, and USDOJ to participate in ACI’s 20th Anniv. Drug & Medical Litigation

NEW YORK - Aug. 20, 2015 - PRLog -- American Conference Institute (ACI) is pleased to announce that over 75 speakers, including 30 plus in-house counsel from drug and medical device companies and 12 Judges, will present at its 20th Anniversary Drug and Med conference in New York on December 2-4, 2015.

Visit us online for more details: http://drugandmed.com/index.html

This year’s lineup of speakers includes:

·         The Honorable Ruben Castillo, Chief Judge, United States District Court, Northern District of Illinois

·         The Honorable Joy Flowers Conti, Chief Judge, United States District Court for the Western District of Pennsylvania

·         The Honorable Michael J. Davis, United States District Judge, District of Minnesota

·         The Honorable Eldon E. Fallon, United States District Judge, Eastern District of Louisiana

·         The Honorable David R. Herndon, United States District Judge, Southern District of Illinois

·         The Honorable Ed Kinkeade, District Judge, United States District Court, Northern District of Texas

·         The Honorable Leslie E. Kobayashi, United States District Judge, District of Hawaii

·         The Honorable Richard A. Kramer, Judge, San Francisco County Superior Court

·         The Honorable J. Frederick Motz, Senior Judge, United States District Court, District of Maryland

·         The Honorable Arnold L. New, Supervising Judge, Court of Common Pleas, Trial Division – Civil

·         The Honorable Christopher A. Nuechterlein, Magistrate Judge, United States District Court, Northern District of Indiana

·         Jacob T. Elberg, Chief, Health Care & Government Fraud Unit, United States Attorney's Office, District of New Jersey

·         Charlene Keller Fullmer, Assistant United States Attorney and Deputy Chief, Affirmative Litigation, United States Attorney's Office, Eastern District of Pennsylvania

·         Carmen M. Ortiz, United States Attorney, District of Massachusetts

·         Sonia Chen Arnold, Counsel- Litigation and Legal Compliance, Eli Lilly and Company

·         Jason Baranski, Senior Vice President, Associate General Counsel, Shire Pharmaceuticals

·         Patricia A. Barbieri, Deputy General Counsel, Legal Affairs, Daiichi Sankyo, Inc.

·         Donald P. Bunnin, Senior Litigation Counsel, Allergan plc

·         Candace Camarata, Assistant General Counsel, Litigation & Investigations, C.R. Bard,  Inc.

·         March D. Coleman, Director, Legal,Merck & Co., Inc.

·         Blaine R. Dart, Senior Corporate Counsel, Litigation, Investigations & Risk Management, Zimmer Biomet

·         Howard L. Dorfman, Senior Vice President and General Counsel, Turing Pharmaceuticals

·         Jennifer E. Dubas, Vice President, Litigation & Risk, Endo Pharmaceuticals

·         Courtney Camp Enloe, Lead Counsel, Litigation,McKesson

·         Patrick L. Gibson, Director, Government Investigations, Merck & Co., Inc.

·         J. Byron Hayes, Senior Litigation Counsel, Zimmer Biomet

·         Max C. Heerman, Principal Litigation Counsel, Medtronic, Inc.

·         Sarah Heineman, Senior Counsel, Bayer Corporation

·         Jean F. Holloway, Vice President, General Counsel & Secretary, CryoLife, Inc.

·         Michael J. Hulka, General Counsel and Senior Director, Strategy and Operations, Lilly Oncology, Eli Lilly and Company

·         Michael W. King, Corporate Counsel, Novo Nordisk Inc.

·         Cynthia J. Kretz, Vice President, General Counsel, Cook Group Incorporated

·         James W. A. Ladner, Deputy General Counsel – Litigation & Investigations, St. Jude Medical, Inc.

·         Joanne R. Lane, Associate Director , Merck & Co., Inc.

·         David M. Layfer, Counsel, Abbvie

·         Christopher D. Liwski, Senior Corporate Counsel, NA Litigation & Investigations, Sanofi US

·         Connie Matteo, Assistant General Counsel, Pfizer Inc.

·         Jason Maxwell, Assistant General Counsel, Litigation and Compliance, Takeda Pharmaceuticals

·         Rita A. McConnell, Vice President and Chief Litigation Counsel, Medtronic, Inc.

·         Sarah M. Padgitt, Senior Counsel, Baxter International Inc.

·         Michael P. Panagrossi, Associate General Counsel, Purdue Pharma L.P.

·         Steve Phillips, Special Counsel, Medtronic, Inc.

·         David N. Royster, Vice President, Deputy General Counsel, Zimmer Biomet Holdings, Inc.

·         Richard W. Silbert, V.P., Assoc. General Counsel, Purdue Pharma L.P.

·         Jack C. Silhavy, Executive Vice President & General Counsel , Fresenius Kabi USA

·         Anthony P. Tinari, Vice President and General Counsel, Bracco Diagnostics Inc.

·         Brennan J. Torregrossa, Assistant General Counsel, GlaxoSmithKline

·         Erica L. Visokey, Legal Counsel, Stryker Corporation

·         Allen Waxman, Executive Vice President & General Counsel, Market Access/Law & Government Affairs, Eisai Inc.

More information about this event, including a full agenda, faculty list, and brochure can be accessed at www.drugandmed.com.

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Headquartered in New York and led by  Leigh Gilmore, Senior Vice President, and Seth Kerker, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.